BN Business News
Add your company to Business Communicator →

Regulation & law · 04/09/2015Updated: 10/17/2026 · 1 min read

NIH to Grant Exclusive Patent License for Treating Mitral Valve Regurgitation

The National Institutes of Health is issuing a notice of its intention to grant a worldwide exclusive patent license to practice inventions for treating mitral valve regurgitation, as outlined in the NIH's patent policy

Original source language: Federal Register — All DocumentsOpen original release →

Explore insights

Business insights →